再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09688 再鼎医药

交易中 07-03 15:22:56

13.480

+0.000

0.00%

最高13.660	最低13.220	成交量138.14万
今开13.600	昨收13.480	日振幅3.26%
总市值134.04亿	流通市值134.04亿	总股本9.94亿
成交额1,860万	换手率0.14%	流通股本9.94亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09688","market":"HK","secType":"STK","nameCN":"再鼎医药","latestPrice":13.48,"timestamp":1719991340064,"preClose":13.48,"halted":0,"volume":1381409,"delay":0,"floatShares":994387430,"shares":994387430,"eps":-2.7050405,"marketStatus":"交易中","marketStatusCode":2,"change":0,"latestTime":"07-03 15:22:56","open":13.6,"high":13.66,"low":13.22,"amount":18597186,"amplitude":0.032641,"askPrice":13.5,"askSize":2300,"bidPrice":13.48,"bidSize":2200,"shortable":3,"etf":0,"ttmEps":-2.7317505702946785,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1719994200000},"adr":0,"listingDate":1601222400000,"adjPreClose":13.48,"openAndCloseTimeList":[[1719970200000,1719979200000],[1719982800000,1719993600000]],"volumeRatio":0.490185,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09688","defaultTab":"news","newsList":[{"id":"2448157278","title":"再鼎医药下跌2.08%，报16.93美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448157278","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448157278?lang=zh_cn&edition=full","pubTime":"2024-07-02 22:04","pubTimestamp":1719929042,"startTime":"0","endTime":"0","summary":"7月2日，再鼎医药(ZLAB)盘中下跌2.08%，截至22:04，报16.93美元/股，成交84.02万美元。财务数据显示，截至2024年03月31日，再鼎医药收入总额8714.9万美元，同比增长38.78%；归母净利润-5347.1万美元，同比减少8.8%。大事提醒：8月5日，再鼎医药将披露2024财年中报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/02220441335512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4139","BK4588","BK1161","09688","BK4531","BK1588","BK4548","BK4526","BK1574","BK4585","ZLAB"],"gpt_icon":0},{"id":"2448615889","title":"再鼎医药(09688)：授出购股权及受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2448615889","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448615889?lang=zh_cn&edition=full","pubTime":"2024-07-02 19:50","pubTimestamp":1719921010,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药(09688)发布公告，于2024年7月1日(美国东部时间)，公司根据2024年股权激励计划向1名承授人授出可认购合共600股美国存托股份的购股权并向1名承授人涉及合共900股美国存托股份的受限制股份单位;以及公司根据2024年股权激励计划向杜莹博士授出涉及合共7.2万股美国存托股份的受限制股份单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1144638.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09688","BK4531","BK1161","BK1574","BK4588","BK4585","BK4548","ZLAB","BK4526","BK1588","BK4139"],"gpt_icon":0},{"id":"2446687683","title":"再鼎医药下跌2.11%，报17.15美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446687683","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446687683?lang=zh_cn&edition=full","pubTime":"2024-06-28 23:31","pubTimestamp":1719588708,"startTime":"0","endTime":"0","summary":"6月28日，再鼎医药(ZLAB)盘中下跌2.11%，截至23:31，报17.15美元/股，成交441.41万美元。财务数据显示，截至2024年03月31日，再鼎医药收入总额8714.9万美元，同比增长38.78%；归母净利润-5347.1万美元，同比减少8.8%。大事提醒：8月5日，再鼎医药将披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/06/28233141275628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK1574","BK4526","BK4548","09688","BK4139","ZLAB","BK4531","BK4585","BK1588","BK1161","BK4588"],"gpt_icon":0},{"id":"2446842530","title":"再鼎医药(09688)根据股权激励计划发行170.02万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446842530","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446842530?lang=zh_cn&edition=full","pubTime":"2024-06-27 21:11","pubTimestamp":1719493899,"startTime":"0","endTime":"0","summary":"再鼎医药(09688)发布公告，该公司于2024年6月27日发行170.02万股股...","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_14.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_14.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1141970.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1588","ZLAB","BK1574","BK4548","BK4585","BK4531","BK1161","BK4139","BK4588","09688","BK4526"],"gpt_icon":0},{"id":"2446300990","title":"再鼎医药06月27日主力资金流出321万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2446300990","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446300990?lang=zh_cn&edition=full","pubTime":"2024-06-27 16:16","pubTimestamp":1719476200,"startTime":"0","endTime":"0","summary":"06月27日, 再鼎医药股价跌6.28%，报收13.42元，成交金额4224万元，换手率0.31%，振幅5.73%，量比0.81。再鼎医药今日主力资金净流出321万元，连续3日净流出，上一交易日主力净流出227万元，今日环比增加41.41%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为50.00%，平均跌幅为2.68%。该股近5个交易日下跌3.73%，主力资金累计净流出845万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入5786万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062716170895dd7d7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062716170895dd7d7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1588","BK1574","09688"],"gpt_icon":0},{"id":"2446376720","title":"再鼎医药(09688)下跌5.03%，报13.6元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446376720","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446376720?lang=zh_cn&edition=full","pubTime":"2024-06-27 11:29","pubTimestamp":1719458990,"startTime":"0","endTime":"0","summary":"6月27日，再鼎医药(09688)盘中下跌5.03%，截至11:29，报13.6元/股，成交1212.99万元。再鼎医药有限公司主要业务是研发和销售针对肿瘤、自身免疫性疾病、感染性疾病和中枢神经系统疾病的创新药物，以满足全球患者的医疗需求。关键经营数据方面，公司以其强大的研发能力和全球化运营策略，致力于成为全球领先的生物制药公司。截至2024年一季报，再鼎医药营业总收入6.18亿元、净利润-3.79亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/06/27112941230535.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4139","BK4585","09688","BK4526","BK4588","BK1161","BK4548","ZLAB","BK1588","BK4531","BK1574"],"gpt_icon":0},{"id":"2446376339","title":"再鼎医药盘中异动 早盘急速下跌5.03%报13.601港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446376339","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446376339?lang=zh_cn&edition=full","pubTime":"2024-06-27 11:25","pubTimestamp":1719458706,"startTime":"0","endTime":"0","summary":"2024年06月27日早盘11时25分，再鼎医药股票出现波动，股价大幅下挫5.03%。截至发稿，该股报13.601港元/股，成交量86.8588万股，换手率0.09%，振幅3.91%。资金方面，该股资金流入425.653万港元，流出661.985万港元。再鼎医药股票所在的生物技术行业中，整体跌幅为1.30%。其相关个股中，永泰生物-B、盛禾生物-B、复宏汉霖涨幅较大，振幅较大的相关个股有歌礼制药-B、帝王国际投资、方达控股，振幅分别为15.29%、13.33%、12.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627112506aef6d74b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627112506aef6d74b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1161","BK1574","BK1588"],"gpt_icon":0},{"id":"2446805335","title":"再鼎医药发行230万股奖励股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2446805335","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446805335?lang=zh_cn&edition=full","pubTime":"2024-06-26 07:27","pubTimestamp":1719358042,"startTime":"0","endTime":"0","summary":"再鼎医药（09688）公布，2024年6月25日发行230万股奖励股份。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-06-26/doc-inazzfps0917789.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-06-26/doc-inazzfps0917789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1588","BK1161","BK1574","09688"],"gpt_icon":0},{"id":"2446847065","title":"再鼎医药(09688)发行230万股奖励股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2446847065","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446847065?lang=zh_cn&edition=full","pubTime":"2024-06-25 22:47","pubTimestamp":1719326824,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药(09688)公布，2024年6月25日发行230万股奖励股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1140492.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1588","BK4585","09688","BK1161","BK4526","BK4548","BK4139","ZLAB","BK4588","BK1574","BK4531"],"gpt_icon":0},{"id":"2445909258","title":"高质量国产创新药出海事件再临！港股创新药ETF(159567)跟踪指数趋势上行，康方生物、康希诺生物、再鼎医药领涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2445909258","media":"有连云","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445909258?lang=zh_cn&edition=full","pubTime":"2024-06-24 10:21","pubTimestamp":1719195716,"startTime":"0","endTime":"0","summary":"2024年6月24日，港股创新药板块趋势上行。盘面上，康方生物领涨，康希诺生物、再鼎医药跟涨，港股创新药ETF市场热度较高，过去5个交易日日均成交额达到6194万元。伴随我国药企创新实力的逐步提升，以呋喹替尼为代表的我国高质量国产创新药出海正当时，可重点围绕景气度边际转暖的赛道的优质公司进行布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406241021589f5de898&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406241021589f5de898&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","ZLAB","LU0348784397.USD","09926","LU0348783233.USD","LU1720050803.USD","LU1794554557.SGD","BK1161","BK1515","IE00B543WZ88.USD","LU0417516571.SGD","BK1191","688185","BK1588","BK1574","06185","IE00B5MMRT66.SGD","09688"],"gpt_icon":0},{"id":"2445099496","title":"再鼎医药现涨超3% 根据2024股权激励计划授出约17万股ADSs受限股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2445099496","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445099496?lang=zh_cn&edition=full","pubTime":"2024-06-24 09:50","pubTimestamp":1719193840,"startTime":"0","endTime":"0","summary":"再鼎医药（09688）股价上涨3.06%，现报14.16港元，成交额1740.15万港元。\n　　再鼎医药发布公告，于2024年6月18日，该公司根据2024年股权激励计划向8名承授人授出涉及合共17.0024万股美国存托股份的受限制股份。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-06-24/doc-inazuxrm0868461.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-06-24/doc-inazuxrm0868461.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1574","09688","BK1588","BK1161"],"gpt_icon":0},{"id":"2444878262","title":"再鼎医药06月20日获主力加仓756万元 环比增加779.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444878262","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444878262?lang=zh_cn&edition=full","pubTime":"2024-06-20 16:15","pubTimestamp":1718871348,"startTime":"0","endTime":"0","summary":"06月20日, 再鼎医药股价跌2.79%，报收13.94元，成交金额5121万元，换手率0.37%，振幅3.91%，量比1.23。再鼎医药今日主力资金净流入756万元，上一交易日主力净流入86万元，今日环比增加779.07%。该股近5个交易日下跌11.98%，主力资金累计净流入338万元；近20日主力资金累计净流入9614万元，其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406201616009f51c024&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406201616009f51c024&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1161","BK1574","BK1588"],"gpt_icon":0},{"id":"2444282105","title":"再鼎医药根据2024年股权激励计划授出约17万股受限制股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2444282105","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444282105?lang=zh_cn&edition=full","pubTime":"2024-06-20 07:58","pubTimestamp":1718841480,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　再鼎医药（09688）发布公告，于2024年6月18日，该公司根据2024年股权激励计划向8名承授人授出涉及合共17.0024万股美国存托股份的受限制股份。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-06-20/doc-inazisxq2294756.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-06-20/doc-inazisxq2294756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4548","BK4526","BK4531","09688","BK4588","ZLAB","BK1161","BK4139","BK1574","BK4585","BK1588"],"gpt_icon":0},{"id":"2444647299","title":"再鼎医药(09688)根据2024年股权激励计划授出约17万股受限制股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2444647299","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444647299?lang=zh_cn&edition=full","pubTime":"2024-06-19 22:05","pubTimestamp":1718805941,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药(09688)发布公告，于2024年6月18日，该公司根据2024年股权激励计划向8名承授人授出涉及合共17.0024万股美国存托股份的受限制股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1137700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK4526","BK4548","09688","BK4139","ZLAB","BK4531","BK4585","BK1588","BK1161","BK4588"],"gpt_icon":0},{"id":"2443954698","title":"再鼎医药(09688)下跌5.17%，报15.04元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2443954698","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443954698?lang=zh_cn&edition=full","pubTime":"2024-06-14 10:19","pubTimestamp":1718331598,"startTime":"0","endTime":"0","summary":"6月14日，再鼎医药(09688)盘中下跌5.17%，截至10:19，报15.04元/股，成交1549.24万元。再鼎医药有限公司主要业务是研发和销售针对肿瘤、自身免疫性疾病、感染性疾病和中枢神经系统疾病的创新药物，以满足全球患者的医疗需求。关键经营数据方面，公司以其强大的研发能力和全球化运营策略，致力于成为全球领先的生物制药公司。截至2024年一季报，再鼎医药营业总收入6.18亿元、净利润-3.79亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/06/14101941018405.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09688","BK1161","BK4526","BK1588","BK4588","BK4548","ZLAB","BK4531","BK4139","BK1574","BK4585"],"gpt_icon":0},{"id":"2443660094","title":"再鼎医药盘中异动 股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443660094","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443660094?lang=zh_cn&edition=full","pubTime":"2024-06-14 10:19","pubTimestamp":1718331593,"startTime":"0","endTime":"0","summary":"2024年06月14日早盘10时19分，再鼎医药股票出现波动，股价急速下挫5.18%。截至发稿，该股报15.040港元/股，成交量101.58万股，换手率0.10%，振幅3.66%。再鼎医药股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，亚盛医药-B、荣昌生物、基石药业-B涨幅较大，振幅较大的相关个股有亚盛医药-B、晶泰科技、泰格医药，振幅分别为13.01%、10.00%、7.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614101953aef4ecc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614101953aef4ecc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09688","BK1588","BK1574"],"gpt_icon":0},{"id":"2443982406","title":"再鼎医药(09688)股价下跌5.044%，现价港币$15.06","url":"https://stock-news.laohu8.com/highlight/detail?id=2443982406","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443982406?lang=zh_cn&edition=full","pubTime":"2024-06-14 10:19","pubTimestamp":1718331540,"startTime":"0","endTime":"0","summary":"[下跌股]再鼎医药(09688) 股价在上午10:19比前收市价下跌5.044%，现股价为港币$15.06。至目前为止，今日最高价为$15.6，而最低价为$15.06。总成交量为98.39万股，总成交金额为港币$1.5千万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240614947/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09688","BK4588","ZLAB","BK1574","BK4139","BK1588","BK4548","BK1161","BK4526","BK4531","BK4585"],"gpt_icon":0},{"id":"2443635037","title":"再鼎医药下跌2.05%，报19.59美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2443635037","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443635037?lang=zh_cn&edition=full","pubTime":"2024-06-14 00:29","pubTimestamp":1718296177,"startTime":"0","endTime":"0","summary":"6月14日，再鼎医药(ZLAB)盘中下跌2.05%，截至00:29，报19.59美元/股，成交410.31万美元。财务数据显示，截至2024年03月31日，再鼎医药收入总额8714.9万美元，同比增长38.78%；归母净利润-5347.1万美元，同比减少8.8%。大事提醒：8月5日，再鼎医药将披露2024财年中报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/06/14002941012808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4139","BK4548","BK4585","BK4526","BK4588","BK4531","09688","BK1588","BK1574","ZLAB","BK1161"],"gpt_icon":0},{"id":"2442326112","title":"再鼎医药(09688)：中枢神经系统、自身免疫及感染性疾病领域全球开发负责人Harald Reinhart即将退休","url":"https://stock-news.laohu8.com/highlight/detail?id=2442326112","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442326112?lang=zh_cn&edition=full","pubTime":"2024-06-12 07:09","pubTimestamp":1718147362,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药(09688)发布公告，再鼎医药总裁，中枢神经系统、自身免疫及感染性疾病领域(NSAiID)全球开发负责人Harald Reinhart博士，在完成其杰出的职业生涯之后，将于6月底退休并担任公司的高级顾问。Reinhart博士退休后，再鼎医药总裁，全球肿瘤研发负责人Rafael Amado博士的职责范围将扩大，负责公司全球研发全部工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1133884.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1588","ZLAB","BK1161","BK4531","BK4585","BK4548","BK4139","BK4588","BK1574","BK4526","09688"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zailaboratory.com","stockEarnings":[{"period":"1week","weight":-0.06},{"period":"1month","weight":-0.0792},{"period":"3month","weight":0.0819},{"period":"6month","weight":-0.3535},{"period":"1year","weight":-0.4049},{"period":"ytd","weight":-0.373}],"compareEarnings":[{"period":"1week","weight":-0.0168},{"period":"1month","weight":-0.0172},{"period":"3month","weight":0.0624},{"period":"6month","weight":0.0675},{"period":"1year","weight":-0.0796},{"period":"ytd","weight":0.0423}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Zai Lab Ltd是一家主要从事生物制药的控股公司该公司致力于发现或许可、开发和商业化专有疗法，以解决中国市场中大量未满足医疗需求的领域，包括肿瘤学、自身免疫和传染病。该公司拥有从发现阶段到临床项目后期的一系列专利候选药物。其中包括Niraparib（ZL-2306）、ZL-2103和ZL-1101等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.016509},{"month":2,"riseRate":0.5,"avgChangeRate":-0.001648},{"month":3,"riseRate":0,"avgChangeRate":-0.143693},{"month":4,"riseRate":0.75,"avgChangeRate":0.076104},{"month":5,"riseRate":0.5,"avgChangeRate":-0.025575},{"month":6,"riseRate":0.25,"avgChangeRate":-0.052584},{"month":7,"riseRate":0.75,"avgChangeRate":0.038393},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.00144},{"month":9,"riseRate":0,"avgChangeRate":-0.186765},{"month":10,"riseRate":0.5,"avgChangeRate":-0.079493},{"month":11,"riseRate":0.75,"avgChangeRate":0.139277},{"month":12,"riseRate":0.5,"avgChangeRate":0.014831}],"exchange":"SEHK","name":"再鼎医药","nameEN":"ZAI LAB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供再鼎医药(09688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"再鼎医药,09688,再鼎医药股票,再鼎医药股票老虎,再鼎医药股票老虎国际,再鼎医药行情,再鼎医药股票行情,再鼎医药股价,再鼎医药股市,再鼎医药股票价格,再鼎医药股票交易,再鼎医药股票购买,再鼎医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供再鼎医药(09688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}